AMPA (amino-3-hydroxy-5-methylisoxazole-4-propionic acid) Receptors in human brain tissues

References

• Watkins J. C., Evans R. H. Excitatory amino acid transmitters. Ann.Rev.Pharmacol.Toxicol. 1981; 21: 165–204
   PubMed Web of Science ®Google Scholar
• Boulter J., Maron C., Heinemann S. Molecular cloning and functional expression of glutamate receptor subunit genes. Science 1990; 249: 1033–1037
   PubMed Web of Science ®Google Scholar
• Moriyoshi K., Mizuno N., Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature 1991; 354: 31–37
   PubMed Web of Science ®Google Scholar
• Choi D. W., Rothman S. M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Ann.Rev.Neurosci. 1990; 13: 171–182
   PubMed Web of Science ®Google Scholar
• Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. TIPS 1990; 11: 379–387
   PubMed Web of Science ®Google Scholar
• Beal M. F. Mechanisms of excitotoxicity in neurologic diseases. FASEB J. 1992; 6: 3338–3344
   PubMed Web of Science ®Google Scholar
• Coyle J. T., Puttfarcken P. Oxidative stress. glutamate, and neurodegenerative disorders. Science 1993; 262: 689–695
   Google Scholar
• Benveniste H., Schousboe A., Diemer N. H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J.Neurochem. 1984; 43: 1369–1374
   PubMed Web of Science ®Google Scholar
• Hara H. Pharmacological prevention of ischemia-induced brain damage. Drugs of Today 1994; 30: 123–144
   Google Scholar
• Sheardown M. J., Jacobsen P., Honoré T. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia. Science 1990; 247: 571–574
   PubMed Web of Science ®Google Scholar
• Sheardown M. J., Suzdak P. D., Nordholm L. AMPA but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h. Eur. J. Pharmacol. 1993; 236: 347–353
   PubMedGoogle Scholar
• Gill R., Nordholm L., Lodge D. The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model. Brain Res. 1992; 580: 35–43
   PubMed Web of Science ®Google Scholar
• Nellgard B., Wieloch T. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. J.Cereb.Blood Flow Metab. 1992; 12: 2–11
   PubMed Web of Science ®Google Scholar
• Collingridge G. L., Lester R. A.J. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol.Rev. 1989; 41: 143–210
   PubMed Web of Science ®Google Scholar
• Craig A. M., Blackstone C. D., Huganir R. L., Banker G. The distribution of glutamate receptors in cultured rat hippocampal neurons: Postsynaptic clustering of AMPA-selective subunits. Neuron 1993; 10: 1055–1068
   PubMedGoogle Scholar
• Monaghan D. T., Yao D., Cotman C. W. Distribution of [3H]AMPA binding sites in rat brain as determined by quantitative autoradiography. Brain Res. 1984; 324: 160–164
   PubMed Web of Science ®Google Scholar
• Rainbow T. C., Wieczorek C. M., Halpain S. Quantitative autoradiography of binding sites for [3HAMPA a structural analogue of glutamic acid. Brain Res. 1984; 309: 173–177
   Google Scholar
• Kurumaji A., Ishimaru M., Toru M. α-[3H]Amino-3-hydroxy-5-methylisoxazole-4-propionicacid binding to human cerebral cortical membranes: minimal changes in postmortem brains of chronic schizophrenics. J.Neurochem. 1992; 59: 829–837
   PubMedGoogle Scholar
• Verdoorn T. A., Dingledine R. Excitatory amino acid receptors expressed in Xenopus oocytes: agonist pharmacology. Mol.Pharmacol. 1988; 34: 298–307
   Google Scholar
• Keinänen K., Sakmann B., Seeburg P. H. A family of AMPA-selective glutamate receptors. Science 1990; 249: 556–560
   PubMed Web of Science ®Google Scholar
• Nakanishi N., Shneider N. A., Axel R. A family of glutamate receptor genes: evidence for the formation of heteromultimeric receptors with distinct channel properties. Neuron 1990; 5: 569–581
   PubMed Web of Science ®Google Scholar
• Olsen R. W., Szamraj O., Houser C. R. [3H]AMPA binding to glutamate receptor subpopulations in rat brain. Brain Res. 1987; 402: 243–254
   Google Scholar
• Honoré T., Drejer J. Chaotropic ions affect the conformation of quisqualate receptors in rat cortical membranes. J.Neurochem. 1988; 51: 475–461
   Google Scholar
• Hunter C., Wheaton K. D., Wenthold R. J. Solubilization and partial purification of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding sites from rat brain. J.Neurochem. 1990; 54: 118–125
   Google Scholar
• Hall R. A., Kessler M., Lynch G. Evidence that high- and low-affinity DL-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) binding sites reflect membrane-dependent states of a single receptor. J.Neurochem. 1992; 59: 1997–2004
   Google Scholar
• Honoré T., Laurisden J., Krogsgaard-Larsen P. The binding of [3H]-AMPA a structural analogue of glutamic acid, to rat brain membranes. J. Neurochem. 1982; 38: 173–178
   PubMed Web of Science ®Google Scholar
• Sommer B., Sakmann B., Seeburg P. H. Flip and flop: A specific functional switch in glutamate-operated channels of the CNS. Science 1990; 249: 1580–1585
   PubMed Web of Science ®Google Scholar
• Pellegrini-Giampietro D. E., Bennett M. V.L., Zukin R. S. Differential expression of three glutamate receptor genes in developing rat brain: An in situ hybridization study. Proc.Natl.Acad.Sci.USA 1991; 88: 4157–4161
   Google Scholar
• Sun W., Ferrer-Montiel A. V., Schinder A. F., McPherson J. P., Evans G. A., Montal M. Molecular cloning. chromosomal mapping, and functional expression of human brain glutamate receptors. Proc.Natl.Acad.Sci.USA 1992; 89: 1433–1447
   Google Scholar
• Sachais B. S., Snider R. M., Lowe J. A., III, Krause J. E. Molecular basis for the species selectivity of the substance P antagonist CP-96,345. J.Biol.Chem. 1993; 268: 2319–2323
   PubMed Web of Science ®Google Scholar
• Appell K. C., Singh S., Tomczuk B. E. Antagonists that demonstrate species differences in neurokinin-1 receptors. Mol.Pharmacol. 1992; 41: 772–778
   PubMed Web of Science ®Google Scholar
• Oksenberg D., Marsters S. A., O'Dowd B. F., Jin H., Havlik S., Peroutka S. J., Ashkenazi A. A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT18 receptors. Nature 1992; 360: 161–163
   PubMed Web of Science ®Google Scholar
• Subramanyam S., Ault B., Sawutz D., Bacon E. R., Singh B., Pennock P. O., Kelly M. D., Kraynak M., Krafte D., Treasurywala A. 6-(4-pyridinyl)-1H-1,2,3-triazolo[4,5-d)-pyrimidin-4(5H)-one: a structurally novel competitive AMPA receptor antagonist. J. Med. chem. 1995; 38: 587–589
   PubMed Web of Science ®Google Scholar